These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 9163888

  • 1. Salmon calcitonin and calcium in the treatment of male osteoporosis: the effect on bone mineral density.
    Erlacher L, Kettenbach J, Kiener H, Graninger W, Kainberger F, Pietschmann P.
    Wien Klin Wochenschr; 1997 Apr 25; 109(8):270-4. PubMed ID: 9163888
    [Abstract] [Full Text] [Related]

  • 2. [Effects of salmon calcitonin in treatment of osteoporosis in patients undergoing dialysis].
    Wang SX, Li H.
    Zhonghua Yi Xue Za Zhi; 2008 Feb 05; 88(6):387-90. PubMed ID: 18581891
    [Abstract] [Full Text] [Related]

  • 3. Salmon calcitonin in prevention of osteoporosis in maintenance dialysis patients.
    Wang SX, Li H.
    Chin Med J (Engl); 2008 Jul 20; 121(14):1280-4. PubMed ID: 18713548
    [Abstract] [Full Text] [Related]

  • 4. The effect of intranasal salmon calcitonin therapy on bone mineral density in idiopathic male osteoporosis without vertebral fractures--an open label study.
    Tóth E, Csupor E, Mészáros S, Ferencz V, Németh L, McCloskey EV, Horváth C.
    Bone; 2005 Jan 20; 36(1):47-51. PubMed ID: 15664001
    [Abstract] [Full Text] [Related]

  • 5. The effects of daily alendronate, daily calcitonin and alendronate every other day on bone mineral density in osteoporotic men.
    Guven Z, Karadag-Saygi E, Unlu-Ozkan F, Akyuz G.
    Aging Male; 2007 Dec 20; 10(4):197-201. PubMed ID: 18033629
    [Abstract] [Full Text] [Related]

  • 6. Skeletal effects of cyclic recombinant human growth hormone and salmon calcitonin in osteopenic postmenopausal women.
    Holloway L, Kohlmeier L, Kent K, Marcus R.
    J Clin Endocrinol Metab; 1997 Apr 20; 82(4):1111-7. PubMed ID: 9100582
    [Abstract] [Full Text] [Related]

  • 7. Long-term (3 years) prevention of trabecular postmenopausal bone loss with low-dose intermittent nasal salmon calcitonin.
    Reginster JY, Denis D, Deroisy R, Lecart MP, De Longueville M, Zegels B, Sarlet N, Noirfalisse P, Franchimont P.
    J Bone Miner Res; 1994 Jan 20; 9(1):69-73. PubMed ID: 8154311
    [Abstract] [Full Text] [Related]

  • 8. [Sequential calcitriol-calcitonin in the therapy of osteoporosis].
    Passeri M, Palummeri E, Barbagallo M, Butturini L, Pedrazzoni M, Davoli L, Pioli G, Benassi L, Girasole G, Ciotti G.
    Minerva Endocrinol; 1989 Jan 20; 14(1):57-62. PubMed ID: 2659953
    [Abstract] [Full Text] [Related]

  • 9. Increase of axial and appendicular trabecular and cortical bone density in established osteoporosis with intermittent nasal salmon calcitonin therapy.
    Peichl P, Rintelen B, Kumpan W, Bröll H.
    Gynecol Endocrinol; 1999 Feb 20; 13(1):7-14. PubMed ID: 10368793
    [Abstract] [Full Text] [Related]

  • 10. Total and regional bone mineral content and fracture rate in postmenopausal osteoporosis treated with salmon calcitonin: a prospective study.
    Rico H, Revilla M, Hernández ER, Villa LF, Alvarez de Buergo M.
    Calcif Tissue Int; 1995 Mar 20; 56(3):181-5. PubMed ID: 7750020
    [Abstract] [Full Text] [Related]

  • 11. A prospective study of bone loss and turnover after cardiac transplantation: effect of calcium supplementation with or without calcitonin.
    Välimäki MJ, Kinnunen K, Tähtelä R, Löyttyniemi E, Laitinen K, Mäkelä P, Keto P, Nieminen M.
    Osteoporos Int; 1999 Mar 20; 10(2):128-36. PubMed ID: 10501793
    [Abstract] [Full Text] [Related]

  • 12. [Clinical efficacy of treatment with salmon calcitonin, administered intranasally for 1 year, in stabilized postmenopausal osteoporosis].
    Agnusdei D, Gonnelli S, Camporeale A, Batignani T, Nardi P, Ianes A, Gennari C.
    Minerva Endocrinol; 1989 Mar 20; 14(3):169-76. PubMed ID: 2695815
    [Abstract] [Full Text] [Related]

  • 13. [Treatment of primary osteoporosis with calcium and salmon calcitonin].
    Ringe JD.
    Dtsch Med Wochenschr; 1990 Aug 03; 115(31-32):1176-82. PubMed ID: 2199180
    [Abstract] [Full Text] [Related]

  • 14. [Salmon calcitonin in the treatment of osteoporosis].
    Payer J, Killinger Z, Ondrejka P.
    Vnitr Lek; 1999 Aug 03; 45(8):476-9. PubMed ID: 11045148
    [Abstract] [Full Text] [Related]

  • 15. A randomized controlled trial to compare the efficacy of cyclical parathyroid hormone versus cyclical parathyroid hormone and sequential calcitonin to improve bone mass in postmenopausal women with osteoporosis.
    Hodsman AB, Fraher LJ, Watson PH, Ostbye T, Stitt LW, Adachi JD, Taves DH, Drost D.
    J Clin Endocrinol Metab; 1997 Feb 03; 82(2):620-8. PubMed ID: 9024265
    [Abstract] [Full Text] [Related]

  • 16. Effect of long-term calcitonin administration on steroid-induced osteoporosis after cardiac transplantation.
    Kapetanakis EI, Antonopoulos AS, Antoniou TA, Theodoraki KA, Zarkalis DA, Sfirakis PD, Chilidou DA, Alivizatos PA.
    J Heart Lung Transplant; 2005 May 03; 24(5):526-32. PubMed ID: 15896748
    [Abstract] [Full Text] [Related]

  • 17. A prospective study of bone loss and turnover after allogeneic bone marrow transplantation: effect of calcium supplementation with or without calcitonin.
    Välimäki MJ, Kinnunen K, Volin L, Tähtelä R, Löyttyniemi E, Laitinen K, Mäkelä P, Keto P, Ruutu T.
    Bone Marrow Transplant; 1999 Feb 03; 23(4):355-61. PubMed ID: 10100579
    [Abstract] [Full Text] [Related]

  • 18. A randomized controlled trial of salmon calcitonin to prevent bone loss in corticosteroid-treated temporal arteritis and polymyalgia rheumatica.
    Healey JH, Paget SA, Williams-Russo P, Szatrowski TP, Schneider R, Spiera H, Mitnick H, Ales K, Schwartzberg P.
    Calcif Tissue Int; 1996 Feb 03; 58(2):73-80. PubMed ID: 8998681
    [Abstract] [Full Text] [Related]

  • 19. Effects of salmon calcitonin treatment on serum and synovial fluid bone formation and resorption markers in osteoporosis patients.
    Atbinici H, Sipahioğlu S, Aksoy N, Baykara İ, Işıkan UE.
    Acta Orthop Traumatol Turc; 2015 Feb 03; 49(2):160-5. PubMed ID: 26012937
    [Abstract] [Full Text] [Related]

  • 20. Combined treatment with calcitonin and 1,25-dihydroxyvitamin D3 for osteoporosis in women.
    Eriksson SA, Lindgren JU.
    Calcif Tissue Int; 1993 Jul 03; 53(1):26-8. PubMed ID: 8348381
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.